Inogen Inc (INGN) Earnings History

Inogen Inc - Q4 2025 EarningsMet

Filed at: Feb 24, 2026, 4:06 PM EST|Read from source

EXECUTIVE SUMMARY

Inogen reported a mixed financial performance for Q4 2025, with modest revenue growth driven by international sales but offset by declines in U.S. segments. The company demonstrated significant progress in improving profitability, achieving positive adjusted EBITDA for the full year 2025 and reducing net loss year-over-year, supported by operational efficiencies and cost reductions.

POSITIVE HIGHLIGHTS

  • •

    Full year 2025 revenue increased 3.9% to $348.7 million, primarily driven by higher growth in international POC sales of 18.4%.

    positive
  • •

    Full year 2025 Adjusted EBITDA was positive $2.7 million, an improvement of 128.4% compared to negative $9.5 million in the prior year.

    positive
  • •

    GAAP net loss for the full year 2025 improved by 36.6% to $22.7 million compared to $35.9 million in the prior year.

    positive
  • •

    Authorized a $30.0 million share repurchase program.

    positive

CONCERNS & RISKS

  • •

    Total revenue in the fourth quarter of 2025 increased by only 2.0% to $81.7 million, primarily driven by higher growth in international POC sales of 14.8%, partially offset by lower U.S. sales (-5.1%) and U.S. rentals (-4.5%).

    attention
  • •

    Total gross margin decreased to 43.1% in Q4 2025 from 45.3% in the prior-year period, primarily the result of channel mix.

    attention
  • •

    Full year 2025 gross margin decreased to 44.2% from 46.1% in 2024, primarily due to changing channel mix from higher POC sales to business customers.

    attention
  • •

    Net rental patients decreased to 49,000 as of December 31, 2025, from 51,000 in the prior year.

    attention
  • •

    Inventories increased to $25.9 million as of December 31, 2025, from $24.8 million as of December 31, 2024.

    attention
  • •

    Full year 2026 revenue guidance is projected to be in the range of $366 million to $373 million, reflecting approximately 6% growth at the midpoint, which is a deceleration from the 3.9% growth in 2025.

    attention

FINANCIAL METRICS

Revenue
Quarterly
$81.72B
+2.0%
Prior year: $80.08B
Annual (YTD)
$348.67B
N/A
Prior year: $335.70B
Net Income
Quarterly
$-7.13B
-27.0%
Prior year: $-9.76B
Annual (YTD)
$-22.75B
N/A
Prior year: $-35.89B
EPS (Diluted)
Quarterly
$-0.26
-36.6%
Prior year: $-0.41
Annual (YTD)
$-0.86
N/A
Prior year: $-1.52
Operating Income
Quarterly
$-9.31B
+18.3%
Prior year: $-11.39B
Annual (YTD)
$-30.21B
N/A
Prior year: $-42.52B
EPS (Basic)
Quarterly
N/A
N/A

MARGIN ANALYSIS

Gross Margin
Current Quarter
43.1%
Prior Year
45.3%
YoY Change
-220 bps
Operating Margin
Current Quarter
-11.4%
Prior Year
-14.2%
YoY Change
+283 bps
Net Margin
Current Quarter
-8.7%
Prior Year
-12.2%
YoY Change
+346 bps

Margin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.

REVENUE BY SEGMENT — Q4 2025 2025

VISUAL OVERVIEW

|
U.S. sales
0.0%
N/A
CC: -3.1%
International sales
0.0%
N/A
CC: +18.1%
U.S. rentals
0.0%
N/A
CC: -6.3%

DETAILED BREAKDOWN

|
SegmentCurrentPrior YrYoY% TotalCC
U.S. sales
N/A———-3.1%
International sales
N/A———+18.1%
U.S. rentals
N/A———-6.3%
Total Revenue$0.00M——100.0%—

Segment performance shows business unit health and growth drivers. Constant currency (CC) removes FX impact for like-for-like comparison.

MANAGEMENT GUIDANCE

FY2026

revenue
$366000.0B—$373000.0B
Mid-point: $369500.0B
"approximately 6% growth at the midpoint"
Adjusted EBITDA
"positive Adjusted EBITDA improvement"

Q1 2026

revenue
"in line with first quarter 2025"

Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.

MANAGEMENT COMMENTARY

In 2025, we made significant progress toward our long-term profitability goals while strengthening our product portfolio and improving the fundamentals of our business.

— Inogen Inc, Q4 2025 2025 Earnings Call

Our disciplined operational efficiency contributed to a substantial year-over-year improvement in adjusted EBITDA, culminating in a positive result for the first time since 2021.

— Inogen Inc, Q4 2025 2025 Earnings Call

Our strong balance sheet with no debt, puts us in a strong position to accelerate innovation, enhance customer engagement, and drive portfolio expansion in 2026 and beyond.

— Inogen Inc, Q4 2025 2025 Earnings Call

Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.

OPERATIONAL METRICS

Net rental patients as of period-end
49.0K
-3.9% YoY
Prior year: 51.0K
Units Sold
46.3K
+20.6% YoY
Prior year: 38.4K

Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.